The Scientist

» transparency

Most Recent

image: Feds Demand More Clinical Trial Reporting

Feds Demand More Clinical Trial Reporting

By | September 19, 2016

Expanded US Health and Human Services rules will require the results of more human studies to be made public.

1 Comment

image: Journal to Publish Clinical Trial Protocols

Journal to Publish Clinical Trial Protocols

By | May 18, 2016

Following an independent group’s finding of misreported outcomes, the Annals of Internal Medicine now requires that authors include clinical trial protocols when submitting their results.

0 Comments

image: How to Use P-Values Correctly

How to Use P-Values Correctly

By | March 9, 2016

The American Statistical Association offers guidance on best practices for the oft-misused tool.

1 Comment

image: Study: Transparency Lacking in Biomedical Literature

Study: Transparency Lacking in Biomedical Literature

By | January 4, 2016

Few authors make their full data available and most published papers do not clearly state funding sources and conflicts of interest.

3 Comments

image: Clinical Trial Data Underreported: Study

Clinical Trial Data Underreported: Study

By | November 16, 2015

One-third of the human experiments for approved drugs failed transparency requirements.

0 Comments

image: Using FOIA to Read Scientists’ Emails

Using FOIA to Read Scientists’ Emails

By | September 8, 2015

Journalists and activists use the Freedom of Information Act to expose academics’ relationships with industry.

2 Comments

image: More Transparency in IRB-Industry Ties

More Transparency in IRB-Industry Ties

By | July 13, 2015

Conflicts of interest among institutional review board members are disclosed more often than they were a decade ago, according to a survey of academics.

0 Comments

image: Device Trials Go Unpublished

Device Trials Go Unpublished

By | June 24, 2015

Just half of the clinical studies used to gain premarket approval for cardiac devices ever make it into the scientific literature.

0 Comments

image: EPA Reform Bills Considered

EPA Reform Bills Considered

By | March 5, 2015

If passed, Republican-led efforts to change the US Environmental Protection Agency’s handling of science may never make it past the President’s desk.

2 Comments

image: IOM Urges Data Sharing

IOM Urges Data Sharing

By | January 15, 2015

The Institute of Medicine says results from human clinical trials ought to be made available to independent researchers within 18 months.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech